X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs ELDER PHARMA - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS ELDER PHARMA J.B.CHEMICALS/
ELDER PHARMA
 
P/E (TTM) x 17.3 -0.2 - View Chart
P/BV x 2.2 0.1 2,167.3% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 J.B.CHEMICALS   ELDER PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
ELDER PHARMA
Jun-14
J.B.CHEMICALS/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs363380 95.6%   
Low Rs255188 135.6%   
Sales per share (Unadj.) Rs169.1491.2 34.4%  
Earnings per share (Unadj.) Rs16.6-3.2 -521.7%  
Cash flow per share (Unadj.) Rs23.414.4 162.5%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs172.5376.5 45.8%  
Shares outstanding (eoy) m83.5720.54 406.9%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.80.6 316.0%   
Avg P/E ratio x18.6-89.3 -20.9%  
P/CF ratio (eoy) x13.219.7 67.0%  
Price / Book Value ratio x1.80.8 237.5%  
Dividend payout %12.00-   
Avg Mkt Cap Rs m25,8275,833 442.8%   
No. of employees `0003.8NA-   
Total wages/salary Rs m2,5112,179 115.2%   
Avg. sales/employee Rs Th3,747.4NM-  
Avg. wages/employee Rs Th665.7NM-  
Avg. net profit/employee Rs Th367.8NM-  
INCOME DATA
Net Sales Rs m14,13510,089 140.1%  
Other income Rs m366257 142.6%   
Total revenues Rs m14,50110,346 140.2%   
Gross profit Rs m2,178-792 -275.1%  
Depreciation Rs m570361 157.7%   
Interest Rs m352,756 1.3%   
Profit before tax Rs m1,940-3,653 -53.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m552125 441.3%   
Profit after tax Rs m1,387-65 -2,122.7%  
Gross profit margin %15.4-7.8 -196.3%  
Effective tax rate %28.5-3.4 -831.2%   
Net profit margin %9.8-0.6 -1,515.1%  
BALANCE SHEET DATA
Current assets Rs m10,4709,240 113.3%   
Current liabilities Rs m2,7499,998 27.5%   
Net working cap to sales %54.6-7.5 -727.3%  
Current ratio x3.80.9 412.1%  
Inventory Days Days5546 119.2%  
Debtors Days Days7860 129.6%  
Net fixed assets Rs m5,81110,124 57.4%   
Share capital Rs m167206 81.2%   
"Free" reserves Rs m14,2485,582 255.2%   
Net worth Rs m14,4167,734 186.4%   
Long term debt Rs m04,889 0.0%   
Total assets Rs m17,64922,882 77.1%  
Interest coverage x56.6-0.3 -17,391.5%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.80.4 181.6%   
Return on assets %8.111.8 68.5%  
Return on equity %9.6-0.8 -1,138.8%  
Return on capital %13.722.3 61.4%  
Exports to sales %03.0 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs mNA43 0.0%   
Fx inflow Rs m6,164307 2,010.4%   
Fx outflow Rs m1,334125 1,065.0%   
Net fx Rs m4,829181 2,663.8%   
CASH FLOW
From Operations Rs m1,23111,754 10.5%  
From Investments Rs m-208-561 37.1%  
From Financial Activity Rs m-595-6,762 8.8%  
Net Cashflow Rs m4274,432 9.6%  

Share Holding

Indian Promoters % 55.4 39.6 139.9%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 7.5 45.2%  
FIIs % 3.9 16.8 23.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 36.1 102.5%  
Shareholders   30,437 16,479 184.7%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   ALKEM LABORATORIES  PLETHICO PHARMA  FDC LTD.  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Wipro's Q1FY20 Result, Crude Oil Prices, and Top Cues in Focus Today(Pre-Open)

On Wednesday, share markets in India traded on a positive note most of the day and ended marginally higher.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jul 17, 2019 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - NOVARTIS COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS